AfterNext HealthTech Acquisition, a blank check company backed by TPG targeting healthcare technology, filed on Friday with the SEC to raise up to $300 million in an initial public offering.
The Fort Worth, TX-based company plans to raise $300 million by offering 30 million units at $10 per unit. Each unit contains one share of common stock and one-fourth of a warrant, exercisable at $11.50. At the proposed deal size, the company would command a market value of $375 million.
AfterNext HealthTech Acquisition is led by CEO and Chairman Halsey Wise, former CEO and Chairman of MedAssets and Integraph, President and Director Anthony Colaluca, former CFO and EVP of MedAssets and Integraph, and CFO Martin Davidson, Partner and CAO of TPG Capital. The company aims to leverage management's experience to target businesses that lie at the intersection of healthcare and technology.
The company was founded in 2021 and plans to list on the NYSE under the symbol AFTR.U. AfterNext HealthTech Acquisition filed confidentially on June 7, 2021. Goldman Sachs, Deutsche Bank, and BofA Securities are the joint bookrunners on the deal.
